Enoxaparin-induced skin necrosis: A fatal outcome

American Journal of Therapeutics

Volumn 14, Issue 4, 2007, Pages 408-410

  Singh, Sarabjeet ^a,b   Verma, Meenakshi ^a   Bahekar, Amol ^a   Agrawal, Preeti ^a   Duggal, Jasleen ^a   Iliescu, Maria ^a   Khosla, Pam ^a   Muzaffar, Shirin ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

Enoxaparin; Low molecular weight heparin; Skin necrosis

Indexed keywords

ENOXAPARIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

AFRICAN AMERICAN; AGED; ANTITHROMBIN DEFICIENCY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG WITHDRAWAL; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HUMAN TISSUE; LUNG EMBOLISM; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; SEPSIS; SKIN DEFECT; SKIN NECROSIS;

AFRICAN AMERICANS; AGED, 80 AND OVER; ANTICOAGULANTS; ENOXAPARIN; FATAL OUTCOME; FEMALE; HUMANS; NECROSIS; SKIN; VENOUS THROMBOSIS;

EID: 34547657246     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3180325905     Document Type: Article

References (8)

1. Noble S, Peters DH, Goa KL. Enoxaparin: a reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease. Drugs. 1995;49:388-410.
2. Spiro TE, Johnson GJ, Christie MJ, et al. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Ann Intern Med. 1994;121:81-89.
3. Litin SC, Heit JA, Mees KA. Use of low-molecular-weight heparin in the treatment of venous thromboembolic disease: answers to frequently asked questions. The Thrombophilia Center Investigators. Mayo Clin Proc. 1998;73:545-550.
4. Walenga JM, Frenkel EP, Bick RL. Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other adverse effects of heparin-type therapy. Hematol Oncol Clin North Am. 2003;17:259-282, viii-ix.
5. Wutschert R, Piletta P, Bounameaux H. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention. Drug Safety. 1999;20:515-525.
6. Nadir Y, Mazor Y, Reuven B, et al. A fatal case of enoxaparin induced skin necrosis and thrombophilia. Eur J Haematol. 2006;77:166-168.
7. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121:535-555.
8. Warkentin TE, Whitlock RP, Teoh KH. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis. Am J Hematol. 2004;75:56-62.